Clinical Trials Browser

Phase 3 × Multiple Myeloma × In Situ Hybridization, Fluorescence × Clear all

NCT00217438 2015-08-21

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Phase 3 Completed

130 enrolled 6 charts

Multiple Myeloma